» Authors » Sergey Zozulya

Sergey Zozulya

Explore the profile of Sergey Zozulya including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 888
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bondarchuk T, Vaskiv D, Zhuravel E, Shyshlyk O, Hrynyshyn Y, Nedialko O, et al.
Bioconjug Chem . 2024 Jul; 35(8):1172-1181. PMID: 38994647
Enzymatic site-specific bioconjugation techniques, in particular sortase-mediated ligation, are increasingly used to generate conjugated proteins for a wide array of applications. Extension of the utility and practicality of sortagging for...
2.
Chernykh A, Aloshyn D, Kuchkovska Y, Daniliuc C, Tolmachova N, Kondratov I, et al.
Org Biomol Chem . 2022 Sep; 20(47):9337-9350. PMID: 36107003
A series of all stereoisomers of β-CF or β-CF substituted prolines and their dipeptide derivatives were synthesized. Mouse plasma stability assay was carried out to study the impact of fluoroalkyl...
3.
Lukin A, Bakholdina A, Chudinov M, Onopchenko O, Zhuravel E, Zozulya S, et al.
J Enzyme Inhib Med Chem . 2021 Jul; 36(1):1651-1658. PMID: 34294008
A set of 1,3,4-thiadiazole-2-carboxamides bearing a substituted biphenyl in the amide portion was synthesised and tested for agonistic activity towards free fatty acid receptor 1 (FFA1). The observed activity trends...
4.
Lukin A, Bakholdina A, Zhurilo N, Onopchenko O, Zhuravel E, Zozulya S, et al.
Arch Pharm (Weinheim) . 2020 Dec; 354(4):e2000275. PMID: 33270252
Three types of heterocyclic moieties-piperidines fused to a heteroaromatic moiety-were explored as potential periphery motifs for the pharmacophoric core of fasiglifam (TAK-875), with fasiglifam being the most advanced agonist of...
5.
Adams V, Gussen V, Zozulya S, Cruz A, Moriscot A, Linke A, et al.
Cells . 2020 Oct; 9(10). PMID: 33050629
Patients with malignant tumors frequently suffer during disease progression from a syndrome referred to as cancer cachexia (CaCax): CaCax includes skeletal muscle atrophy and weakness, loss of bodyweight, and fat...
6.
Malashchuk A, Chernykh A, Hurmach V, Platonov M, Onopchenko O, Zozulya S, et al.
J Mol Struct . 2020 Jul; 1210. PMID: 32655187
With the aim of circumventing the adverse /-isomerization of combretastatin A4 (CA4), a naturally occurring tumor-vascular disrupting agent, we designed novel CA4 analogs bearing 1,3-cyclobutane moiety instead of the -stilbene...
7.
Kuranov S, Luzina O, Onopchenko O, Pishel I, Zozulya S, Gureev M, et al.
Bioorg Chem . 2020 Apr; 99:103830. PMID: 32289588
Six derivatives of 3-phenylpropionic acid bearing various natural and natural-like, spatially defined peripheral motifs have been synthesized and evaluated in vitro for free fatty acid receptor 1 (FFA1) activation. Two...
8.
Chiba S, Ohue M, Gryniukova A, Borysko P, Zozulya S, Yasuo N, et al.
Sci Rep . 2019 Dec; 9(1):19585. PMID: 31863054
Potential inhibitors of a target biomolecule, NAD-dependent deacetylase Sirtuin 1, were identified by a contest-based approach, in which participants were asked to propose a prioritized list of 400 compounds from...
9.
Krasavin M, Kalinin S, Zozulya S, Gryniukova A, Borysko P, Angeli A, et al.
J Enzyme Inhib Med Chem . 2019 Dec; 35(1):306-310. PMID: 31797704
The differential scanning fluorimetry (DSF) screening of 5.692 fragments in combination with benzenesulfonamide (BSA) against bovine carbonic anhydrase (CA) delivered >100 hits that either caused, on their own, a significant...
10.
Krasavin M, Kalinin S, Zozulya S, Griniukova A, Borysko P, Angeli A, et al.
J Enzyme Inhib Med Chem . 2019 Nov; 35(1):165-171. PMID: 31752557
Testing of an expanded, 800-compound set of analogues of the earlier described Strecker-type α-aminonitriles (selected from publicly available Enamine Ltd. Screening Collection) in thermal shift assay against bovine carbonic anhydrase...